Selective Serotonin Reuptake Inhibitors (SSRIs) are types of antidepressants. Brand names of SSRIs include: Paxil, Zoloft, Celexa, Prozac, Lexapro, Symbyax, Wellbutrin and Effexor. These drugs inhibit neuronal serotonin and norepinephrine reuptake and slightly inhibit dopamine reuptake. SSRIs have been associated with serious, life-threatening birth defects. Research suggests that, if a mother took SSRI’s during pregnancy, […]
SC AG Files Lawsuit Against GSK for Improper Marketing of Diabetes Drug
June 3, 2011
Drug Regulators in the US and Europe Restrict Use of Avandia (rosiglitazone)
September 23, 2010
NHTSA Raises Number of Deaths Associated with Toyota Acceleration
May 26, 2010
Toyota Pays $16.4 Million Fine
May 19, 2010
Toyota Announces Plan to Replace Accelerators in Secondary Recall
March 23, 2010
Congressman Stupak Calls on FDA to Assure Whistleblower Keeps His Job
The Food and Drug Administration (FDA) asked whistleblower Dr. David Graham to leave his position and move elsewhere in the agency, according to Congressman Bart Stupak (D-MI).
Dr. Graham, a 20 year veteran at the FDA, recently testified before the Senate Finance Committee about FDA oversight on certain drugs, such as Vioxx®. In his testimony, Dr. Graham states "I would argue that the FDA, as currently configured, is incapable of protecting America against another Vioxx®."
The Committee also asked if there should be any other drugs that should be pulled from the market, which Dr. Graham named five: Accutane®, Meridia®, Crestor®, Bextra®, and Serevent®.
After Dr. Graham gave his testimony the Committee feels that the treatment of Dr. Graham will have a chilling effect on FDA employees to speak up and disagree when they believe the public’s health is at risk.
If you or a loved one were injured through the use of a pharmaceutical product or dietary supplement please use the form below to contact our law firm.